Colon Cancer
Conditions
Keywords
colon cancer, circulating DNA, Exercise, Meal
Brief summary
The study of circulating tumoral DNA makes it possible to study, without invasive procedures or pathological studies, the tumoral DNA circulating in the blood of a patient and its various alterations. In patients with colon-rectal cancer with resected tumor, circulating tumor DNA can be used as a predictive biomarker of metastatic relapse of cancer. However, the routine extension of circulating tumoral DNA remains limited due to several difficulties. One of the pifalls that circulating tumor DNA is greatly diluted by healthy circulating DNA from non-tumor cells. The amount of healthy circulating DNA has been described as being influenced by certain physiological parameters. The aim of the study is to increase knowledge on the influence of physiological factors associated with sports activity and meal on the release kinetics of circulating DNA.
Detailed description
20 subjects free of malignancy (Male-Female Ratio 2 to 1) the variation in the concentration of DNA circulating between the value measured on an empty stomach after 1 hour of rest, then at the end of each of the successive stages of moderate intensity physical effort: pedaling 15 minutes at 75 Watt then 100 Watt of the ergometer. Dosages will be repeated after 15, 30 and 60 minutes of recovery. After an hour of recovery, the subject will be asked to consume a meal rich in fat. The circulating DNA will be measured 2 hours after the end of the meal. 40 patients with colon cancer will be enrolled for a two visit study. The first visit will be planned at the first cycle of chemotherapy, before the chemotherapy. At this visit, the influence of exercise on plasma concentrations of circulating free DNA will also be studied in 40 patients with colon cancer. Free circulating DNA will be measured on an empty stomach after 1 hour of rest, then immediately after low-intensity physical effort : pedaling 3 minutes at the 30 Watt level of the ergometer) and after 15, 30 and 60 minutes of recovery. After an hour of recovery, the subject will be proposed to consume a meal rich in fat. The circulating DNA will be measured 2 hours after the end of the meal. The second visit will be planned at the first second of chemotherapy, before the chemotherapy. Free circulating DNA will be measured on an empty stomach after 1 hour of rest, then immediately after low-intensity physical effort : pedaling 3 min at the 30 Watt level of the ergometer, and after 15, 30 and 60 minutes of recovery.
Interventions
OTHERModerate intensity physical effort
Pedaling 15 minutes at 75 Watt then 100 Watt of the ergometer
OTHERLow intensity physical effort
Pedaling 3 minutes at the 30 Watt level of the ergometer
OTHERHyperlipidic meal
Eating an hyperlipidic meal 60 minutes after a physical effort
DIAGNOSTIC_TESTMeasure of circulating DNA
Multiple measure of circulating DNA: on an empty stomach, at the end of the physical effort, after 15, 30 and 60 minutes of rest, 120 minutes after an hyperlipidic meal. An additional measure will occur for subjects free of malignancy during the effort.
Sponsors
Eurofins Biomnis
Assistance Publique - Hôpitaux de Paris
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE
Intervention model description
Physiological pilot study-two groups
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes
Inclusion criteria
1. Subjects free of malignancy * men or women 40-70 yrs aged 2. Patients with colon cancer * men or women 18-85 yrs aged * Biopsy-proven colon cancer with indication to chemiotherapy * Chemiotherapy (first line or second line) not started
Exclusion criteria
1. All subjects * Ischemic cardiac history * known heart disease * blood hemoglobin concentration \<8g / dl * Acute or chronic systemic illnesses, (apart from diabetes, essential or secondary hypertension for patients) * Pregnancy or breastfeeding or in progress 2. Subjects free of malignancy * Cardiovascular risk factor (active smoking or greater than 10 pack-years, diabetes, hypertension or known dyslipidemia not controlled by the diet) * Glomerular filtration rate estimated by the CKD epi (Chronic Kidney Disease - Epidemiology Collaboration) formula \< 60 ml.min-1.1.73 m-² * Contraindication to exercise * Drug taking in progress (except estrogen-progestogen contraception)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in circulating DNA induced by moderate effort in subjects free of malignacy | 0, 3, 15 minutes of exercise, 15, 30 and 60 minutes of recovery. | Variation in the concentration of circulating DNA between the value measured after 1 hour of rest, during and at recovery of moderate intensity physical effort |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in circulating DNA induced by hyperlipidic meal in subjects free of malignacy | 0 minutes (before eating) and 120 minutes after eating | Variation in the concentration of circulating DNA between the value measured before and after an hyperlipidic meal in subjects free of malignancy |
| Change in circulating DNA induced by moderate effort in patients with colon cancer | 0, 15, 30 and 60 minutes of recovery. | Variation in the concentration of circulating DNA between the value measured after 1 hour of rest, during and at recovery of low intensity physical effort |
| Change in circulating DNA induced by hyperlipidic meal in patients with colon cancer | 0 minutes (before eating) and 120 minutes after eating | Variation in the concentration of circulating DNA between the value measured before and after an hyperlipidic meal |
Countries
France
Contacts
Primary ContactAnnie BERGERA
Outcome results
None listed